Skip to content

Clinical study on the effect of different proportion of ropivacaine and bupivacaine on the occurrence of limb phantom

Clinical study on the effect of different proportion of ropivacaine and bupivacaine on the occurrence of limb phantom

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058100
Enrollment
Unknown
Registered
2022-03-29
Start date
2022-04-10
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intraspinal anesthesia/limb phantom

Interventions

Group A:1% ropivacaine 1.5ml+ 1.5ml water for injection sterilization
Group B:1% ropivacaine 1.5ml+50% glucose 0.2ml+ cerebrospinal fluid 1.3ml
Group C:0.75% bupivacaine 2ml+ 1ml water for injection sterilization
Group D:0.75% bupivacaine 2ml+50% glucose 0.2ml+ cerebrospinal fluid 0.8ml

Sponsors

Affiliated Hospital of Yan'an University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade ?-?; 2. Aged between 18 and 59 years; 3. BMI 18.5-27.9kg/m^2; 4. Patients undergoing lower extremity and lower abdomen surgery under combined lumbar and epidural anesthesia; 5. No abnormal communication and cognitive ability.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to intraspinal anesthesia; 2. Blockade failure or poor effect; 3. Patients with motor and sensory disorders before surgery; 4. Mental and nervous system diseases.

Design outcomes

Primary

MeasureTime frame
Limb phantom incidence and type;Time to extinction of the limb phantom;

Secondary

MeasureTime frame
Time of onset of anesthesia;Duration of anesthesia;Highest level of arrest;Onset time of motor block;Muscle strength measurement criteria;Adverse reactions;Patient anesthesia satisfaction survey;

Countries

China

Contacts

Public ContactLi Lingxia
Lilingxia-197307@163.com+86 15891180098

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026